Monitor the trajectory of Term Life segment income, which declined 12% YoY due to lower remeasurement gains and higher expenses, and watch for continued ISP sales momentum as a driver of overall earnings growth.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $288.96entry
- T+1 · 11d ago +0.56%α +0.25% · $290.58
- T+5 · 5d ago +1.04%α −2.25% · $291.96
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Primerica reported Q3 2026 results with total revenues of $902 million (+7% YoY) and diluted EPS of $6.76 (+6% YoY), slightly above the consensus estimate of $6.38. Investment and Savings Products segment drove growth with record sales of $4.4 billion (+19% YoY) and client asset values reaching $140 billion, while Term Life Insurance segment income declined 12% YoY due to lower remeasurement gains and higher expenses. The company returned $159 million to stockholders through buybacks and dividends.
Key Financial Metrics
Key Facts
- Total revenues of $902 million increased 7% YoY from $840 million
- Diluted EPS of $6.76 increased 6% YoY from $6.35
- Adjusted diluted operating EPS of $6.77 increased 7% YoY from $6.33
- ISP sales increased 19% YoY to $4.4 billion
- Client asset values ended at $140 billion, up 10% YoY
- Term Life Insurance adjusted operating income declined 12% YoY to $152.7 million
- Returned $159 million to stockholders via $122 million share repurchases and $37 million dividends
- Life-licensed sales force declined 3% YoY to 147,058 representatives
Financial Impact
Total revenues $901.7M, net income $209.1M, diluted EPS $6.76 vs consensus $6.38
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Term Life Insurance | $461.6M | -0.4% |
| Investment and Savings Products | $378.0M | +18.6% |
| Corporate and Other Distributed Products | $62.2M | +9.6% |
Risk Factors
- Term Life segment income declined 12% YoY, driven by lower remeasurement gains and higher insurance expenses
- Life-licensed sales force continued to shrink, down 3% YoY to 147,058 representatives
- Issued term life face amount decreased 5% YoY to $25.7 billion
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-447427 |
| Document: pri-ex99_1.htm | 0001193125-26-447427 |
| Document: pri-20261104.htm | 0001193125-26-447427 |
| Document: 0001193125-26-447427-index-headers.html | 0001193125-26-447427 |
| Document: 0001193125-26-447427-index.html | 0001193125-26-447427 |
| Document: 0001193125-26-447427.txt | 0001193125-26-447427 |
| 8-K Data (Synthetic) | 0001193125-26-447427 |
Track record
9 reports on PRI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $304.13 Now $295.44 −2.86% settles Feb 8
- Nov 4, 202612d ago 8-K Neutral 5/10 Viewing Entry $288.96 Now $295.44 +2.24% settles Feb 3
- Aug 17, 202613w ago Insider Cluster Neutral 3/10 Entry $308.21 to $304.13 Now $295.44 −4.14% ▼ −1.32% +0.72% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $310.84 to $288.96 Now $295.44 −4.95% ▼ −7.04% −1.93% vs SPY
- Jul 15, 202617w ago 144 Neutral 2/10 Entry $305.26 to $275.39 Now $295.44 −3.22% ▼ −9.79% −12.32% vs SPY
- Jun 2, 202623w ago 8-K Neutral 3/10 Entry $255.10 to $291.44 Now $295.44 +15.81% ▲ +14.25% +11.75% vs SPY
- May 6, 202627w ago 8-K Bullish 7/10 Entry $273.26 to $317.25 Now $295.44 +8.12% ▲ +16.10% +12.27% vs SPY
- Apr 2, 202632w ago DEFA14A Neutral 2/10 Entry $253.85 to $284.20 Now $295.44 +16.38% ▲ +11.96% −2.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers